RefleXion is a privately-held company developing the first biology-guided radiotherapy (BgRT)* system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. BgRT incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency
The RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT).
*The RefleXion™ X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
Resources
For more information, please contact:
Thorsten Melcher
[email protected]
Cal Huntzinger
[email protected]